Via America’s Lawyer: The FDA is again resorting to damage control, now warning the public about Xeljanz, a rheumatoid arthritis drug approved in 2012 that’s been linked to heart disease and cancer. Attorney Sara Papantonio joins Mike Papantonio to explain the dangerous results from recent safety trials, while the drug still hasn’t been pulled from pharmacies. Transcript: *This transcript was […]

The post Arthritis Drug Xeljanz Linked To Cancer & Heart Disease: FDA FINALLY Ads Black Box Warning appeared first on The Ring of Fire Network.

This post was originally published on The Ring of Fire.